Fastly (FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its ...

Nvidia (NVDA) was in the spotlight on Monday as Piper Sandler named the semiconductor giant its top large-cap pick. Read for more.

Piper Sandler analyst Harsh Kumar raised the firm’s price target on Nvidia (NVDA) to $175 from $140 and keeps an Overweight rating on the ...

Investing.com - Analysts at Piper Sandler have assumed coverage of shares of Block Inc (NYSE:SQ) with an Overweight rating ...

BYD (1211.HK, BYDDY) could ship more cars in 2024 than Ford (F) after the Chinese automaker sold more than 500,000 vehicles ...

Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

Piper Sandler raised the firm’s price target on ACV Auctions (ACVA) to $18 from $16 and keeps a Neutral rating on the shares following ...

Expectations for President-elect Donald Trump to roll out expansionary fiscal policies and extend U.S. economic ...

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...